Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialDavid W. Andrews, Walter J. Curran, William F. Demas et al.|The Lancet|2004Cited by 2.4k
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05Edward Shaw, Nancy Farnan, Charles Scott et al.|International Journal of Radiation Oncology*Biology*Physics|2000Cited by 1.6k
Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report of intergroup study 0034George E. Laramore, Bruce H. Campbell, Charles Scott et al.|International Journal of Radiation Oncology*Biology*Physics|1992Cited by 413
Central pathology review in clinical trials for patients with malignant glioma. A report of radiation therapy oncology group 83-02Charles Scott, Diana F. Nelson, James S. Nelson et al.|Cancer|1995Cited by 89
Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: A report of radiation therapy oncology group (RTOG) 83-02Kevin Murray, Walter J. Curran, Diana F. Nelson et al.|International Journal of Radiation Oncology*Biology*Physics|1995Cited by 60